KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Amortization - Intangibles (2019 - 2025)

Historic Amortization - Intangibles for Bristol Myers Squibb (BMY) over the last 7 years, with Q4 2025 value amounting to $826.0 million.

  • Bristol Myers Squibb's Amortization - Intangibles fell 5121.09% to $826.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.3 billion, marking a year-over-year decrease of 6261.27%. This contributed to the annual value of $3.3 billion for FY2025, which is 6261.27% down from last year.
  • Latest data reveals that Bristol Myers Squibb reported Amortization - Intangibles of $826.0 million as of Q4 2025, which was down 5121.09% from $831.0 million recorded in Q3 2025.
  • Over the past 5 years, Bristol Myers Squibb's Amortization - Intangibles peaked at $2.5 billion during Q2 2021, and registered a low of $826.0 million during Q4 2025.
  • For the 5-year period, Bristol Myers Squibb's Amortization - Intangibles averaged around $2.0 billion, with its median value being $2.4 billion (2022).
  • Its Amortization - Intangibles has fluctuated over the past 5 years, first surged by 1012.27% in 2021, then plummeted by 6564.57% in 2025.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Amortization - Intangibles stood at $2.4 billion in 2021, then dropped by 3.06% to $2.3 billion in 2022, then dropped by 2.77% to $2.3 billion in 2023, then dropped by 25.68% to $1.7 billion in 2024, then crashed by 51.21% to $826.0 million in 2025.
  • Its Amortization - Intangibles was $826.0 million in Q4 2025, compared to $831.0 million in Q3 2025 and $830.0 million in Q2 2025.